Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.

Suppr

超能文献

作者信息

Greenblatt D J, Pfeifer H J, Ochs H R, Franke K, MacLaughlin D S, Smith T W, Koch-Weser J

出版信息

J Pharmacol Exp Ther. 1977 Aug;202(2):365-78.

PMID:577934

Abstract

摘要

相似文献

Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.

J Pharmacol Exp Ther. 1977 Aug;202(2):365-78.

Pharmacokinetic studies of quinidine in patients with arrhythmias.

Circulation. 1977 Jan;55(1):1-7.

Noninteraction of digitoxin and quinidine.洋地黄毒苷与奎尼丁无相互作用。

N Engl J Med. 1980 Sep 18;303(12):672-4. doi: 10.1056/NEJM198009183031205.

Influence of food on the comparative bioavailability of a fast- and slow-release dosage form of quinidine gluconate.

Int J Clin Pharmacol Ther Toxicol. 1983 Jan;21(1):1-9.

Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.两种缓释奎尼丁制剂的稳态生物利用度：葡萄糖酸奎尼丁与硫酸奎尼丁对比。

Clin Ther. 1983;5(4):357-64.

Ventricular ectopy.

J Fam Pract. 1984 Dec;19(6):731-3, 737, 741-2 passim.

Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.

Clin Ther. 1984;7(1):22-7.

[Relative bioavailability and influence of a quinidine retard-formulation on blood-pressure and ECG in healthy volunteers (author's transl)].

Arzneimittelforschung. 1981;31(9):1482-6.

Quinidine-rifampin interaction.

N Engl J Med. 1981 Jun 11;304(24):1466-9. doi: 10.1056/NEJM198106113042405.

[Relative bioavailability of various quinidine preparations in man after a single oral dose].

Pharmazie. 1982 Dec;37(12):848-50.

引用本文的文献

Physiologically-Based Pharmacokinetic Modeling Approach to Predict Rifampin-Mediated Intestinal P-Glycoprotein Induction.基于生理学的药代动力学模型预测利福平介导的肠道 P 糖蛋白诱导作用。

CPT Pharmacometrics Syst Pharmacol. 2019 Sep;8(9):634-642. doi: 10.1002/psp4.12458. Epub 2019 Sep 5.

Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.从体外数据预测体内药物相互作用：纳入药物消除平行途径和抑制剂吸收速率常数的影响。

Br J Clin Pharmacol. 2005 Nov;60(5):508-18. doi: 10.1111/j.1365-2125.2005.02483.x.

Therapeutic drug monitoring of antiarrhythmic drugs.抗心律失常药物的治疗药物监测

Clin Pharmacokinet. 2003;42(7):647-63. doi: 10.2165/00003088-200342070-00004.

Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.奎尼丁对细胞色素P450 2D6的抑制作用及其对西洛他唑代谢的影响。

Clin Pharmacokinet. 1999;37 Suppl 2:41-51. doi: 10.2165/00003088-199937002-00005.

Individual variation in first-pass metabolism.首过代谢的个体差异。

Clin Pharmacokinet. 1993 Oct;25(4):300-28. doi: 10.2165/00003088-199325040-00005.

Gastrointestinal absorption of quinidine from some solutions and commercial tablets.

J Pharmacokinet Biopharm. 1980 Jun;8(3):243-55. doi: 10.1007/BF01059645.

Pharmacokinetics and pharmacodynamics of intravenous digoxin and digitoxin.

Klin Wochenschr. 1981 Aug 17;59(16):889-97. doi: 10.1007/BF01721922.

Bioavailability of quinidine in congestive heart failure.奎尼丁在充血性心力衰竭中的生物利用度。

Br J Clin Pharmacol. 1981 Jun;11(6):571-7. doi: 10.1111/j.1365-2125.1981.tb01173.x.

Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure.丙吡胺在近期发生至中度心力衰竭患者中的药代动力学。

Eur J Clin Pharmacol. 1981 Feb;19(3):187-92. doi: 10.1007/BF00561947.

Intravenous quinidine in congestive cardiomyopathy.

Eur J Clin Pharmacol. 1981 Feb;19(3):173-6. doi: 10.1007/BF00561944.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验